The FDA has taken action by sending warning letters to eight companies that have been marketing unapproved eye products, potentially violating federal laws and risking consumer health. 

These companies include Boiron Inc, CVS Health, Dr. Vitamin Solutions, Natural Ophthalmics Inc., OcluMed LLC, Similasan USA or Similasan AG, TRP Company Inc., and Walgreens Boots Alliance Inc. 

These companies are now under increased scrutiny and may face legal consequences if they fail to comply with FDA regulations. They must either seek FDA approval for their products or remove them from the market to avoid further repercussions. 

Additionally, they need to establish appropriate marketing compliance programs to ensure accurate product labeling. 

Support the show